Case Report
Copyright ©The Author(s) 2020.
World J Clin Cases. Jan 6, 2021; 9(1): 252-261
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.252
Table 1 Characteristics of selected studies
Technique
Ref.
No. of patients/tumors
Follow-up periods/mo, mean ± SD (range)
Follow-up examinations
No. of incomplete ablation
No. of recurrence/mo, post-TA
No. of cervical lymph node metastasis/mo, post-TA
RFAZhang et al[1], 201692/987.8 ± 2.9 (3-18)US, CEUS, and CNB000
RFAKim et al[19], 20176/648.5 ± 12.3 (36-65)FNA and CNB000
RFALuo et al[20], 2017421/440N/A (12-36)US, CEUS and biopsy04 proven; 5 suspicious (N/A)4 (N/A)
RFAJeong et al[21], 20186/719.3 ± 3.5 (15-24)US and CT100
RFAZhang et al[22], 201960/60N/A (18-60)US, CEUS, and CNB000
RFADing et al[23], 201937/38N/A (1-18)CEUS and CT000
RFALim et al[2], 2019133/15239 ± 25 (6-104)US, CT, and biopsy000
RFA1Zhang et al[24], 202094/9464.2 ± 2.8 (median ± SD)US, CEUS, CNB, CT, PET, and bone scan01 (N/A)0
LAZhou et al[25], 201730/3013.2 (12–24)US, CEUS, chest X-ray or CT, and FNA100
LAZhang et al[26], 201864/6425.7 ± 8.2 (12-42)US, CEUS, and FNA201 (30)
LAJi et al[27], 201937/3716.5 ± 6.9 (12-24)US, CEUS, and chest radiographs or CT801 (24)
LA1Zhou et al[28], 201936/3649.2 ± 4.5 (30-54)US, chest X-ray or CT, and FNA01 (42)1 (30)
MWAYue et al[5], 201421/2111 (3-22)US, chest X-ray or CT, and biopsy000
MWA1Li et al[29], 201846/4642US, CEUS, and biopsy000
MWATeng et al[6], 201815/21N/A (36-48)US, CT, and FNA000
MWATeng et al[30], 2019185/20620.7 ± 8.8 (12-36)US and FNA01 (1)0
MWA1Li et al[31], 2019168/16825.1 ± 17.3 (2-60)US and FNA02 (36-44)5 (6-44)
MWAYue et al[32], 2020119/11937.2 ± 20.9 (12-101)US, CEUS, CNB, and CT001 (26)